StockData
NewcelX Ltd. logo

NewcelX Ltd. (NCEL) stock

NCELNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 4/30
$2.54−0.15 (-5.58%)

Close on Nov 20, 2026Market cap $12.19MP/E 1.2Yield –

NewcelX pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

NewcelX's pe ratio was 1.3× on Nov 11, 2026, against 1.7× a year earlier. Over the last 3 years it ranged from 0.8× to 77.7×, with a median of 7.5×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.3×+0.5
2025Dec 31, 20250.8×−17.9
2024Dec 31, 202418.7×–

More NewcelX figures

See a number that looks wrong?